Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Ramelteon in Moderate to Severe COPD
NCT00316992Phase 4Completed
- Sponsor
- Takeda
- Start
- Apr 2006
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ramelteon in Insomnia, sponsored by Takeda. Primary endpoint: Mean oxygen saturation during sleep for the entire night. Started Apr 2006; status: completed.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00316992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316992.